skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Back in the glory days of PHM, CXR, VRX etc I feel like everyone was looking for "doubles". Expectations seem more modest (pot stocks excepted) these days but I am wondering if 5i could highlight 3 stocks in Canada and 3 in the US that have the fundamentals to suggest a possible double in 2019/2020? If you have time, a few words on the expected catalyst for each as to why the runway is long? Deduct credits as required to provide a full reply please.
Read Answer Asked by Tim on February 13, 2019
Q: Can I get your thoughts on the recent announcement of "Intrinsyc’s engagement of Roth Capital Partners, LLC (“Roth”) as a financial advisor with a mandate to accelerate strategic growth opportunities for the Company. The goal of Roth’s mandate, which has been documented by a formal engagement agreement on standard industry terms, is to enhance value for all holders of Intrinsyc common shares."

Thanks
Read Answer Asked by Scott on February 11, 2019
Q: Hi team,

I don't see any questions on this company Cardiol Therapeutics Inc. (CRDL) that did a recent IPO on TSX and hit a 52 week high today. It seems they are in a (speculative) cannabinoid arena with some drugs coming into phase 1 stages in 2019.
What is management history (CEO, CFO, etc.), board of directors, ...ie are they a solid team?
They had a string of announcements (LOI's, exclusive agreements, etc) in 2017 but no real follow-up news in 2018 wrt these signings.
Does their product pipeline seem promising?
How might it compare to Cannimed wrt therapeutic applications?

Is it a company to just watch for now given it's very recent IPO? So many IPO's flop in the first 6 months thus the caution.

Appreciate your insight!

Cheers,
SteveMc
Read Answer Asked by Stephen on February 06, 2019